Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BibbInstruments ABFRA:V0R -4.01%23 EV-to-EBIT is -5.81 as of Aug. 17, 2026. GuruFocus rates FRA:V0R with a GF Score™ of 23/100. The stock has 2 warning signs investors should review. Among 471 Medical Devices & Instruments companies, BibbInstruments AB ranks worse than 212314.01% on this metric.
BibbInstruments AB (FRA:V0R) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
BibbInstruments AB's Enterprise Value for the quarter that ended in Mar. 2026 was €1.95 Mil.
BibbInstruments AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.52 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BibbInstruments AB EV-to-EBIT Related Terms
BibbInstruments AB EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for BibbInstruments AB's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, BibbInstruments AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BibbInstruments AB EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BibbInstruments AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where BibbInstruments AB's EV-to-EBIT falls into.
BibbInstruments AB's current Enterprise Value is €8.80 Mil.
BibbInstruments AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.52 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BibbInstruments AB (FRA:V0R) has a EV-to-EBIT of -5.81 as of Aug. 17, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on BibbInstruments AB and its competitors. According to the industry distribution chart, BibbInstruments AB ranks #999999 out of 471 companies in the Medical Devices & Instruments industry.
Is BibbInstruments AB's EV-to-EBIT too high?
BibbInstruments AB's current EV-to-EBIT is -5.81. Based on the distribution chart, BibbInstruments AB ranks #999999 out of 471 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, BibbInstruments AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does BibbInstruments AB's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, BibbInstruments AB ranks #999999 out of 471 companies for EV-to-EBIT. This places BibbInstruments AB in the lower half of its industry. The industry median EV-to-EBIT is 19.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 19.29, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on BibbInstruments AB and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 19.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BibbInstruments AB's current EV-to-EBIT is -5.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BibbInstruments AB stock overvalued right now?
BibbInstruments AB (FRA:V0R) has a current EV-to-EBIT of -5.81. The current EV-to-EBIT is -5.81. BibbInstruments AB's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For BibbInstruments AB (FRA:V0R), the current EV-to-EBIT is -5.81 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BibbInstruments AB develops disposable biopsy instrumentation under the brand EndoDrill for early detection of cancer tumors, especially in deep-tissue tumors. The product portfolio includes six disposable instruments based on the patented EndoDrill technology and a novel biopsy method still under development. The instruments will be used for tissue sampling (biopsy) of the most common types of cancer, for example; lung, breast, colorectal, prostate and stomach cancer.
23GF Score
Get the complete analysis for FRA:V0R
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:V0R has been successfully added to your 
